Disorders Resulting from Defeats in Lysosomal Function.

Slides:



Advertisements
Similar presentations
ESSENTIALS OF GLYCOBIOLOGY LECTURE 14 DEGRADATION AND TURNOVER OF GLYCOCONJUGATES Hud Freeze.
Advertisements

Gaucher Disease By: Melissa Sanders.
Receptor-Mediated Endocytosis experimental pathway ( II ) Wu Chenzi.
Therapy of enzyme defects: general considerations ● How many organs are affected by the enzyme defect: One organ, a few, or all organs? ● How severe is.
A Proteopathy Disease: Gaucher’s Disease
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
Xeroderma Pigmentosum(XP) 着色性干皮病. We owe our lives to light from the sun,which provides the energy captured during photosynthesis ( 光合作用 ). But the sun.
Lecture 3 clinical immunology Antigen Presenting Cells
Roscoe Brady, M.D. Scientist Emeritus National Institutes of Health Bethesda, Maryland USA.
Gaucher Disease (this is a hereditary disease)
Tay-Sachs Disease: A Recessive Lysosomic Disease
Southeast university genetic center 第四节 细胞质的结构与功能 ( 一 ) The Structure and Function of Cell Cytoplasm.
The structure and function of cell membrane
A Closer Look Ray Molzon
Week 9: Congenital WBC Problems Pelger-Huët Pelger-Huët Chediak-Higashi Chediak-Higashi Alder-Reilly Alder-Reilly Muco- polysaccharidosis Muco- polysaccharidosis.
Developing an in vitro cellular model for Fabry Disease Part II Project Emma Brewer
ESSENTIALS OF GLYCOBIOLOGY
Genetic/Chromosomal Disorder Presentation By: Brian Smith.
TSD Tay-Sachs Disease (TSD) BY GREG DEYOUNG Introduction to Tay-Sachs Disease There are many genetic diseases in the world, some worse than others.
BY: Zach Kimmel. Tay-Sachs disease Tay-Sachs disease is a genetic disorder that is fatal in most occurrences.
Enzymes are ORGANIC CATALYSTS! Enzymes are proteins (made up of amino acids) Enzymes function by lowering the activation energy of reactions. Enzymes.
Enzymes. O Protein O Only act on certain substances called substrates.
The Lysosome and lysosomal storage disorders (LSD) Part 3A Clinical profile of the LSDs Serge Melançon, MD February 2010.
11.1 GENETIC DISORDERS  BACKGROUND INFORMATION (Early 1900s) Sir Archibald Garrod, British physician, discovered patterns of inheritance leading to alkaptonuria—
The Lysosome and lysosomal storage disorders (LSD) Part III A Clinical profile of the LSDs Serge Melançon, MD February 2009.
 is a genetic disorder characterized by high cholesterol levels.  specifically very high levels of low-density lipoprotein in the blood and early cardiovascular.
Which of the Following Organelles Makes Membrane? A. Golgi apparatus B. Nucleus C. Ribosome D. Endoplasmic reticulum.
Human Genetic Disorder Webquest Bianca Hernandez: Disorder Specialist Courtney Okoyeocha: Parent Erike Arias: Genetic Counselor January 29, 2014 Biology.
Disorders Associated with G protein-Coupled Receptors
Immune system 1.Component of immune system
Disorders Resulting from Defects in Lysosomal Function.
LYSOSOMES By: Carmelitta Oakley.
Genetic Testing & Gene Therapy 5.3. Genetic Testing & Gene Therapy (5.3)  Genetic tests look for signs of a disease or disorder in DNA taken from an.
Tay Sachs Disease By Dana Hienbuecher. Other Names Abbreviation: TSD Other names include GM2 gangliosidosis and Hexosaminidase A deficiency Bernard Sachs,
Lecture #7Date _________ n Chapter 17~ From Gene to Protein.
Tay-Sachs By : Brianna and Sydney.
G AUCHER D ISEASE Mary Jauch Persson. D IFFERENT TYPES OF THE DIEASE Type 1-childhood (most common) Enlarge liver Low blood cell level Anaemia Tiredness.
MLAB 1315-Hematology Keri Brophy-Martinez Unit 26: Lipid Storage Diseases.
Lysosomal Storage Diseases. Fabry’s Disease What kind? Symptoms? Enzyme Def? What accumulates? Inheritance Pattern? Sphingolipidosis Peripheral neuropathy,
Where did Tay-Sachs come from && What is it? The disease Tay-Sachs was named after Warren Tay [ ] and Bernard Sachs[ ]. Tay-Sachs is.
Lysosomes By Amanda Paduch. Purposes of Lysosomes Are digestive vesicles that arise from the Golgi apparatus Contain high levels of degrading enzymes.
By Sarah Moudy Also known as Glucocerebrosidase deficiency.
Tay-Sachs Drew Sivertsen. History Tay-Sachs is named after two physicians Warren Tay – was an ophthalmologist who was the first to discover a red dot.
1.Is NS-NPD caused by defect in a single gene or is more than one gene involved? Mutations in the NPC1, NPC2, and SMPD1 genes cause Niemann-Pick disease.
Gene Therapy Mostafa A. Askar NCRRT By M.Sc. In Molecular Biology
Tay-Sachs disease By Marco Rabello July/2005 NS 215 Dr.Williams.
Gaucher Disease (this is a hereditary disease)
Tay-Sachs Disease n What is it? n A degenerative neurological disorder where virtual absence of activity of a lysosomal enzyme, hexosaminidase A n Biochemistry.
LIPID STORAGE DISEASES.
Suvorexant for Insomnia
Presentation On gaucher’s disease
TALIGLUCERASE ALFA DB08876 C2580H3918N680O727S g/mol
Enzyme and gene therapy of enzyme defects
Imiglucerase Protein chemical formula : C2532H3854N672O711S16
External Quality Assessment
Therapy of enzyme defects: general considerations
Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry.
GLYCOLIPIDS ..
DB00103 Category : Enzyme Replacement Agents
Cell Organelles ‘the intracellular specialty shop’
ID DB06720 VELAGLUCERASE ALFA CATEGORY Enzymes.
Gaucher Disease (this is a hereditary disease)
Sphingolipid Disorders
Volume 25, Issue 5, Pages (May 2017)
Enzyme and gene therapy of enzyme defects
Volume 25, Issue 5, Pages (May 2017)
Enzymes.
Metabolism, Cell Surface Organization, and Disease
Lysosomes and Lysosomal Storage Diseases
Presentation transcript:

Disorders Resulting from Defeats in Lysosomal Function

Other lysosomal storage diseases DiseaseEnzyme Deficiency Principle Storage substance consequences G M1 Gangliosid -osis GM1 β- Galactosidase Ganglioside G M1 Mental retardation,liver enlargement,skeletal involvement,death by age 2 Tay-Sachs diease Hexosaminidase AGanglioside G M2 Mental retardation,blindness,death by age 3 Gaucher’ s disease Glucocerebrosi- dase Glucocerebrosi- de Liver and spleen enlargement,erosion of long bones,mental retardation in infantile form only Fabry’s disease α-Galactosidase A Trihexosylceram ide Skin rash,kidney failure,pain in lower extremities Sandhoff’s disease Hexosaminidase A and B Ganglioside G M2 and globoside Similar to Tay-Sachs diease but more rapidly progressing

Disease: Gaucher’s disease Enzyme Deficiency: Glucocerebrosidase ( 葡糖脑苷脂酶 ) Principal Storage Substance: Glucocerebroside ( 葡糖脑苷脂 ) Consequences: Liver and spleen (脾) enlargement,erosion of long bones,mental retardation (迟缓) in infantile form only

If the victims of this disease have been successfully treated ? yes How? The scientists tell us by enzyme replacement therapy

Treated the enzyme with three different glycosidases (糖苷酶) Exposed underlying mannose residues (甘露糖残基) Recognized by mannose receptors on the surface of macrophages (巨噬细胞) Taken up by receptormediated endocytosis (受体介导的胞吞作 用) Delivered the enzymes to the lysosomes

Disease: Fabry’s disease Enzyme Deficiency: Principal Storage Substance: Consequences: α-Galactosidase A 半乳糖苷酶 Trihexosylceramide () Skin rash (疹),kidney failure,pain in lower extremities (四肢)

Many patients with lysosomal storage diseases carry a mutation that destabilizes the encoded enzyme and causes it to misfold. Now, the scientists have found a good way to treat the patients This misfolded proteins are recognized and destroyed,which is the reason these individuals lack the enzyme.

Any competitive inhibitors (抑制 剂 ) of the enzyme α – galactosidase A (for example Galactose) Bind to the enzyme’s active site and hold the mutant enzyme in a native-like structure that enables it to avoid destruction in the ER Departed the ER and transported to lysosomes